Amgen Inc.
USE OF ONCOLYTIC VIRUSES IN THE NEOADJUVANT THERAPY OF CANCER
Last updated:
Abstract:
The invention relates to the use of an oncolytic virus in a neoadjuvant treatment regimen for the treatment of cancer.
Status:
Application
Type:
Utility
Filling date:
26 Mar 2020
Issue date:
7 Jul 2022